Home » Archive

Articles tagged with: Sorafenib

Treatments Under Development »

[ by | Jun 4, 2009 6:56 pm | No Comment ]

Brand Name: Nexavar
Generic Name: sorafenib tosylate
Code Name: BAY 43-9006
Company: Bayer
FDA Clinical Phase: 1, 2

Description:
Sorafenib is a kinase inhibitor that stops cells from dividing and may also prevent the growth of new blood vessels that tumors need for growth (known as angiogenesis). Sorafenib is a drug used to treat advanced kidney cancer and a type of liver cancer. It is also being studied for treating other cancers.

Clinical Trials:
Currently, there are two clinical trials with sorafenib recruiting patients.…

Read the full story »